Fortrea Holdings Inc. Common Stock

FTRE

Fortrea Holdings Inc. (FTRE) is a global contract research organization (CRO) that provides clinical development services to the biopharmaceutical and healthcare industries. The company offers a range of solutions including clinical trial management, data management, biostatistics, and regulatory consulting, supporting the development of new drugs and treatments. Fortrea is focused on delivering innovative and efficient clinical research services to accelerate pharmaceutical development worldwide.

$17.76 -0.16 (-0.89%)
🚫 Fortrea Holdings Inc. Common Stock does not pay dividends

Company News

Global Clinical Trials Market to Reach $176.32 Billion by 2030 as AI and Decentralized Research Accelerate Growth
GlobeNewswire Inc. • Researchandmarkets.Com • July 15, 2026

The global clinical trials market is projected to grow from $127.16 billion in 2025 to $176.32 billion by 2030, with a CAGR of 6.8%. Growth is driven by AI-enabled trial design, decentralized and virtual trials, precision medicine, and real-world evidence studies. North America leads the market while Asia-Pacific is the fastest-growing region. St...

Fortrea to Attend Jefferies Global Healthcare Conference
GlobeNewswire Inc. • Na • June 2, 2026

Fortrea (Nasdaq: FTRE), a leading global contract research organization, announced that CEO Anshul Thakral, CFO Jill McConnell, and SVP of Investor Relations Tracy Krumme will participate in a fireside chat at the Jefferies Global Healthcare Conference on June 4, 2026. The company reported strong first-quarter 2026 performance with a book-to-bill...

Fortrea dévoile Fortrea Intelligent Technology™ : une technologie destinée à permettre aux investigateurs et aux centres d’essais cliniques de mener des essais plus intelligents et mieux intégrés
GlobeNewswire Inc. • Fortrea • April 8, 2026

Fortrea, a leading global contract research organization, announced the launch of Fortrea Intelligent Technology (FIT), an AI-powered suite of solutions designed to revolutionize clinical trial processes. FIT automates workflows, streamlines oversight, and improves productivity for investigators, clinical trial centers, and research teams. The pl...

Fortrea 推出 Fortrea Intelligent Technology™,助力申办方和研究中心开展更智能、更协同的临床试验
GlobeNewswire Inc. • Fortrea • April 8, 2026

Fortrea, a leading global clinical research organization, launched Fortrea Intelligent Technology (FIT), an AI-driven solution suite designed to transform clinical trial operations. FIT automates workflows, streamlines oversight, and provides real-time insights to sponsors, research sites, and study teams. Built on the Xcellerate® platform, the ...

Fortrea 推出 Fortrea Intelligent Technology™ 以助贊助商及研究中心進行更智能、更整合的試驗
GlobeNewswire Inc. • Fortrea • April 8, 2026

Fortrea, a leading global clinical research organization, announced the launch of Fortrea Intelligent Technology (FIT), an AI-powered solution designed to automate workflows and streamline clinical trial operations. Built on the Xcellerate® platform, FIT offers three pillars: full lifecycle trial management, data-driven foresight analytics, and ...

Related Companies